Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC HPK1-IN-3 | 2739844-34-7 | 98.6% | 490.45 | 50 MG
SDP

Catalog No. 5000350628
Encompass_Preferred

HPK1-IN-3 is a potent and selective ATP-competitive hematopoietic progenitor kinase 1 (HPK1; MAP4K1) inhibitor with an IC50 of 0.25 nM. It exhibits IL-2 cellular potency with an EC50 of 108 nM in human peripheral blood mononuclear cells (PBMCs).

  • Potent and selective ATP-competitive hematopoietic progenitor kinase 1 (HPK1; MAP4K1) inhibitor
  • IC50 of 0.25 nM
  • Exhibits IL-2 cellular potency with an EC50 of 108 nM in human peripheral blood mononuclear cells (PBMCs)
  • Treatment shows statistically significant elevation of proinflammatory cytokines IL-6 and TNF-α in a concentration-dependent manner in human monocyte-derived dendritic cells when treated with 0.25-4 μM for 24 hours

Catalog No. 50-003-50628 Supplier Medchemexpress LLC Supplier No. HY13856850MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

HPK1-IN-3 is a potent and selective ATP-competitive hematopoietic progenitor kinase 1 (HPK1; MAP4K1) inhibitor with an IC50 of 0.25 nM. It exhibits IL-2 cellular potency with an EC50 of 108 nM in human peripheral blood mononuclear cells (PBMCs).

  • Potent and selective ATP-competitive hematopoietic progenitor kinase 1 (HPK1; MAP4K1) inhibitor
  • IC50 of 0.25 nM
  • Exhibits IL-2 cellular potency with an EC50 of 108 nM in human peripheral blood mononuclear cells (PBMCs)
  • Treatment shows statistically significant elevation of proinflammatory cytokines IL-6 and TNF-α in a concentration-dependent manner in human monocyte-derived dendritic cells when treated with 0.25-4 μM for 24 hours

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.